Expression of Id2 in Ewing sarcoma of bone and its significance
10.13315/j.cnki.cjcep.2015.01.008
- VernacularTitle:骨尤因肉瘤中分化抑制因子Id2的表达及意义
- Author:
Yi DING
;
Nana ZHANG
;
Xiaoqi SUN
;
Hua WANG
- Publication Type:Journal Article
- Keywords:
Ewing sarcoma of bone;
inhibitor of differentiation 2;
cell cycle protein;
immunohistochemistry
- From:
Chinese Journal of Clinical and Experimental Pathology
2015;(1):32-35
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To study the expression of inhibitor of differentiation 2 (Id2) in Ewing sarcoma of bone as well as the correlation with cell cycle proteins. Methods The expression of Id2, c-Myc, Cyclin D1, p53, p16 and p27 in 45 cases of Ewing sarcoma were detected by immunohistochemical EnVision methods, the relationship between the expression of Id2 and clinicopathologic characteristics and the correlation with cell cycle proteins were analyzed. Results Total expression of Id2 was found in 88. 9% of Ewing sarcoma. Strong expression of Id2 was detected in 33. 3% cases. Higher frequencies of c-Myc and Cyclin D1 immunostaining were observed (66. 7% and 71. 1%, respectively), but lower frequencies of p53, p16 and p27 expression were present (20. 0%, 35. 6% and 28. 9%, respectively). Id2 overexpression displayed a negative relationship with p27 expression (P<0. 05). Among the follow-up of 24 cases, overexpression of Id2 was found more frequency in dead and metastases cases (41. 2%) when compared to that of progres-sion-free survival cases (14. 3%). Conclusions Id2 was extensively expressed in Ewing sarcoma of bone. Overexpression of Id2 and its correlation with p27 expression suggest that this is an important pathway involved in development of Ewing sarcoma. Moreover, Id2 overexpression may predict poor prognosis.
